Copernicus Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $711K | Buy |
12,000
+2,000
| +20% | +$119K | 8.6% | 6 |
|
|
2021
Q2 | $868K | Buy |
10,000
+2,000
| +25% | +$174K | 13.69% | 2 |
|
|
2021
Q1 | $660K | Buy |
8,000
+4,760
| +147% | +$393K | 10.66% | 3 |
|
|
2020
Q4 | $295K | Sell |
3,240
-150,057
| -98% | -$13.7M | 4.6% | 12 |
|
|
2020
Q3 | $6.13M | Sell |
153,297
-2,208
| -1% | -$88.3K | 5.84% | 6 |
|
|
2020
Q2 | $5.34M | Sell |
155,505
-5,454
| -3% | -$187K | 5.85% | 9 |
|
|
2020
Q1 | $3.58M | Sell |
160,959
-1,018
| -0.6% | -$22.6K | 4.33% | 9 |
|
|
2019
Q4 | $3.17M | Buy |
161,977
+86,977
| +116% | +$1.7M | 4.16% | 10 |
|
|
2019
Q3 | $1.17M | Buy |
+75,000
| New | +$1.17M | 1.08% | 16 |
|